Quantinno Capital Management LP Buys 7,174 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Quantinno Capital Management LP grew its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 18.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 46,337 shares of the medical instruments supplier’s stock after purchasing an additional 7,174 shares during the quarter. Quantinno Capital Management LP owned approximately 0.19% of ICU Medical worth $8,444,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Victory Capital Management Inc. increased its holdings in ICU Medical by 2,966.3% in the 2nd quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier’s stock valued at $16,844,000 after buying an additional 137,222 shares during the period. Millennium Management LLC boosted its stake in shares of ICU Medical by 327.8% in the 2nd quarter. Millennium Management LLC now owns 136,070 shares of the medical instruments supplier’s stock valued at $16,158,000 after purchasing an additional 104,264 shares in the last quarter. FMR LLC boosted its stake in shares of ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock valued at $18,968,000 after purchasing an additional 100,345 shares in the last quarter. Granite Investment Partners LLC acquired a new stake in shares of ICU Medical in the 2nd quarter valued at approximately $10,650,000. Finally, F M Investments LLC acquired a new stake in shares of ICU Medical in the 2nd quarter valued at approximately $10,175,000. 96.10% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ICUI has been the topic of a number of research analyst reports. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Jefferies Financial Group started coverage on shares of ICU Medical in a research note on Monday, October 14th. They issued a “hold” rating and a $183.00 price target on the stock. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. KeyCorp lifted their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Finally, Raymond James lifted their target price on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $173.00.

ICU Medical Stock Down 0.6 %

Shares of NASDAQ ICUI opened at $155.65 on Friday. The company has a market capitalization of $3.81 billion, a P/E ratio of -34.06 and a beta of 0.62. ICU Medical, Inc. has a 52-week low of $83.26 and a 52-week high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The company’s 50 day moving average price is $173.16 and its 200-day moving average price is $148.54.

Insider Transactions at ICU Medical

In other news, Director David C. Greenberg sold 972 shares of ICU Medical stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $158.11, for a total value of $153,682.92. Following the completion of the sale, the director now owns 5,037 shares in the company, valued at $796,400.07. The trade was a 16.18 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at $18,665,666.78. This represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 40,364 shares of company stock worth $6,869,878. Company insiders own 6.70% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.